SCHEMBL4098119

SCHEMBL4098119

CCCCCCCC/C=C\CCCCCCCCCCCC(=O)Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALB P02768 1/20 0.51
KMT2A Q03164 3/20 0.48
ELANE P08246 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
POLM Q9NP87 1/20 0.46
POLK Q9UBT6 1/20 0.46
POLL Q9UGP5 1/20 0.46
POLH Q9Y253 1/20 0.46
CNR1 P21554 2/20 0.46
RET P07949 1/20 0.45
PSMB11 A5LHX3 1/20 0.45
PSMA7 O14818 1/20 0.45
PSMB1 P20618 1/20 0.45
PSMA1 P25786 1/20 0.45
PSMA2 P25787 1/20 0.45
PSMA3 P25788 1/20 0.45
PSMA4 P25789 1/20 0.45
PSMB8 P28062 1/20 0.45
PSMB9 P28065 1/20 0.45
PSMA5 P28066 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2520030 1.00 ALB (0.51) ALBKMT2AELANESMN1; SMN2POLM
SCHEMBL19873141 1.00 ALB (0.51) ALBKMT2AELANESMN1; SMN2POLM
SCHEMBL2518734 0.98 ALB (0.49) ALBKMT2AELANESMN1; SMN2POLM
SCHEMBL19873143 0.98 ALB (0.49) ALBKMT2AELANESMN1; SMN2POLM
SCHEMBL29761138 0.98 ALB (0.49) ALBKMT2AELANESMN1; SMN2POLM
SCHEMBL19873149 0.96 ALB (0.47) ALBKMT2ACNR1KDM4ELMNA
SCHEMBL4097832 0.95 ALB (0.46) ALBKMT2AELANESMN1; SMN2POLM
SCHEMBL2516512 0.95 ALB (0.46) ALBKMT2AELANESMN1; SMN2POLM
SCHEMBL4103844 0.94 MGLL (0.47) KMT2ACNR1PSMB11PSMA7PSMB1
SCHEMBL2514966 0.94 ALB (0.56) ALBKMT2ASMN1; SMN2RETTOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9295621-B2 Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant ELC MANAGEMENT LLC (US) 2016-03-29 US disclosed
US-20090035240-A1 Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent ELC MANAGEMENT LLC 2009-02-05 US disclosed
US-20090035237-A1 Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant ELC MANAGEMENT LLC 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090035237-A1 Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant SMURF1, CUTA, SMURF2 ALB 1597/4885KMT2A 1425/4885ELANE 2550/4885
US-20090035240-A1 Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent SMARCC1, RARG, RARA ALB 2833/4885KMT2A 1387/4885ELANE 3490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.